TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q4 2021 (Next →)

Filing Date: Feb 18, 2022

Total Value: $214M (100.0% shares, 0.0% debt)

Holdings (15)

— Iveric Bio, Inc. 13.6%

Value $29.11M Shares 1,741,228 Est. Cost $16.72 Unrealized —

VRDN Viridian Therapeutics Inc 12.2%

Value $25.98M Shares 1,314,000 Est. Cost $18.63 Unrealized 0.0%

COGT Cogent Biosciences, Inc. 11.0%

Value $23.59M Shares 2,750,037 Est. Cost $8.69 Unrealized 0.0%

— CYMABAY THERAPEUTICS, INC. 9.3%

Value $19.96M Shares 5,905,400 Est. Cost $3.38 Unrealized —

— Alpine Immune Sciences, Inc. 7.6%

Value $16.21M Shares 1,170,212 Est. Cost $13.85 Unrealized —

ACRS Aclaris Therapeuitics, Inc. 7.4%

Value $15.73M Shares 1,082,213 Est. Cost $15.15 Unrealized 0.0%

— CHINOOK THERAPEUTICS, INC. 6.7%

Value $14.39M Shares 882,353 Est. Cost $16.31 Unrealized —

TYRA Tyra Biosciences, Inc. 5.6%

Value $11.97M Shares 850,450 Est. Cost $19.87 Unrealized 0.0%

TRDA Entrada Therapeutics, Inc. 5.3%

Value $11.36M Shares 663,694 Est. Cost $17.12 Unrealized —

— Aerovate Therapeutics, Inc. 4.7%

Value $10.06M Shares 853,330 Est. Cost $11.79 Unrealized —

— Magenta Therapeutics, Inc. 4.6%

Value $9.844M Shares 2,222,222 Est. Cost $4.43 Unrealized —

— Akouos, Inc. 4.2%

Value $8.884M Shares 1,045,215 Est. Cost $8.50 Unrealized —

— Merus N.V. 3.4%

Value $7.155M Shares 225,000 Est. Cost $31.80 Unrealized —

ZLAB Zai Lab Limited 2.8%

Value $5.971M Shares 95,000 Est. Cost $62.85 Unrealized —

— Elevation Oncology, Inc. 1.6%

Value $3.341M Shares 555,000 Est. Cost $6.02 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Iveric Bio, Inc.	1,741,228	$29.11M	13.6%	$16.72	—	COMMON STOCK	46583P102
VRDN	Viridian Therapeutics Inc	1,314,000	$25.98M	12.2%	$18.63	0.0%	COMMON STOCK	92790C104
COGT	Cogent Biosciences, Inc.	2,750,037	$23.59M	11.0%	$8.69	0.0%	COMMON STOCK	19240Q201
—	CYMABAY THERAPEUTICS, INC.	5,905,400	$19.96M	9.3%	$3.38	—	COMMON STOCK	23257D103
—	Alpine Immune Sciences, Inc.	1,170,212	$16.21M	7.6%	$13.85	—	COMMON STOCK	02083G100
ACRS	Aclaris Therapeuitics, Inc.	1,082,213	$15.73M	7.4%	$15.15	0.0%	COMMON STOCK	00461U105
—	CHINOOK THERAPEUTICS, INC.	882,353	$14.39M	6.7%	$16.31	—	COMMON STOCK	16961L106
TYRA	Tyra Biosciences, Inc.	850,450	$11.97M	5.6%	$19.87	0.0%	COMMON STOCK	90240B106
TRDA	Entrada Therapeutics, Inc.	663,694	$11.36M	5.3%	$17.12	—	COMMON STOCK	29384C108
—	Aerovate Therapeutics, Inc.	853,330	$10.06M	4.7%	$11.79	—	COMMON STOCK	008064107
—	Magenta Therapeutics, Inc.	2,222,222	$9.844M	4.6%	$4.43	—	COMMON STOCK	55910K108
—	Akouos, Inc.	1,045,215	$8.884M	4.2%	$8.50	—	COMMON STOCK	00973J101
—	Merus N.V.	225,000	$7.155M	3.4%	$31.80	—	COMMON STOCK	N5749R100
ZLAB	Zai Lab Limited	95,000	$5.971M	2.8%	$62.85	—	COMMON STOCK	98887Q104
—	Elevation Oncology, Inc.	555,000	$3.341M	1.6%	$6.02	—	COMMON STOCK	28623U101